NNAST Terms of reference

  • NNAST will support Nigerian Center for Disease Control and Prevention in its effort to fight Antimicrobial Resistance in Nigeria and the actualization of the four national AMS core elements at national, subnational, and healthcare facility levels, in line with the AMR NAP 2.0, the national AMS Sub-TWG, and the Antimicrobial Resistance Coordination Committee (AMRCC) by:
  • 1. NNAST will help strengthen the national, subnational, and healthcare facility-based AMS programs by:
    o Providing technical support to the AMS-TWG and the AMRCC to ensure AMS activities align with the National Action Plan.
    o Helping to review the AMS program to look for gaps and duplication in data funding and programs.
    o Helping develop advocacy tools for healthcare administrators and policymakers to promote AMS at the subnational and healthcare facility level.
    o Helping increase information on AMR in Nigeria through antimicrobial stewardship efforts, including surveillance, identification of resistant organisms, interpretation of data, management of infections caused by resistant and other organisms, research, education, and policymaking.
    o Assisting with the review and validation of national AMS, Antimicrobial Use (AMU), and AMC strategies and protocols.
    o Supporting the AMS-TWG and the AMRCC to mobilize resources for the AMS program scale-up at all levels of healthcare.
    o Promoting rational antimicrobial use through evidence-based practices and local data on AMR
  • 2. NNAST will:
    Support the review and development of relevant regulations and guidelines (National regulations and guidelines)
    o Collaborate with the relevant regulatory authorities (NAFDAC, PCN, MDCN) to review and or develop protocols for appropriate antimicrobial acquisition, use, and distribution.
    o Support the national AMS sub-TWG and collaborate with the national Essential Medicine List (NEML) committee to review the NEML, standard treatment guidelines using locally generated evidence.
    o Assist and support healthcare facilities to develop facility-specific antibiotic use guidelines based on locally generated data.
    o Assist in monitoring the impact of the AMS program in Nigeria by implementing regular performance and surveillance reviews using predefined AMR indicators.
  • 3. NNAST will help:
    o Strengthen AMS education and training among the healthcare workforce.
    o Support the AMS-TWG to review and validate the existing training resources on antimicrobial and diagnostic stewardship)
    o Design and help to coordinate training programs for multidisciplinary healthcare workers on antimicrobial stewardship (Clinicians, Pharmacists, IPC nurses, Laboratory scientists, Administrators, medical record staff, IT personnel)
    o Collaborate with the national AMR Awareness sub-TWG to develop pre-service (Undergraduate) and post-service training programs (Postgraduate colleges).
  • 4. NNAST will help to:
    Promote the use of technology, research, and evidence-based data for decision-making
    o Assist in establishing an integrated AMS data management system: Collaborate with the AMS sub-TWG to develop a unified platform that helps consolidate surveillance data on resistant pathogens, antimicrobials and stewardship protocols, and relevant information thereby enhancing local evidence-based decision-making and effective communication across National, subnational, and healthcare facility levels.
    o Collaborate with the AMS sub-TWG to advocate for the establishment and deployment of electronic medical record systems at healthcare facilities to ensure appropriate AMS-related data capture and management.
    o Support the AMR surveillance sub-TWG to review and or develop a diagnostic stewardship toolkit for regional healthcare systems to promote the appropriate use of antimicrobials based on locally generated data.
    o Assist with the establishment of a database that would collate and coordinate research activities on antimicrobial stewardship in Nigeria.
    o Help encourage and coordinate research studies on AMR and AMS in Nigeria
  • 5. NNAST will:
    Work closely with the National AMR committee to improve collaboration and coordination of agencies, both governmental and NGOs working on AMR in NIgeria
    Meet regularly to discuss updates, progress, and activities, as well as the engagement of new agencies and groups working on AMR in Nigeria.
    Facilitate the engagement of new agencies or groups working on AMR, ensuring that all key stakeholders remain informed and actively involved in decision-making
    Work with the AMRCC to mobilize funds and other support for the Antimicrobial Stewardship Program. activities in Nigeria
antibiotics resistance in nigeria

 

NNAST will support NCDC and other agencies working on AMR in Nigeria by helping to
Nationalize the strategy for combating Antimicrobial Resistance (AMR) and its consequences in Nigeria.
Increase information known about infectious pathogens and resistant patterns in Nigeria.
Collate existing polices on AMR in Nigeria.
Align existing and new policies on AMR in Nigeria.
Align with agencies doing existing work on AMR in Nigeria.
Interface and collaborate with researchers and research activities on AMR in Nigeria.
Research and review all known information and publications about AMR in Nigeria.
Establish AMR leadership in States and Local Government Areas throughout the country.
Establish laboratory and equipment infrastructure to assist with identifying drug resistant pathogens in various parts of the country.
Establish effective surveillance systems for collection and analyses of data regarding throughout the Country
Coordinate effective processes for AMR pattern surveillance and monitoring across states and Local Government areas.
Establish an integrated digital information platform network to assist in communication, coordination, sharing and dissemination of information on AMR in Nigeria across the system.
Implement and coordinate the process for AMR surveillance, collection, transmission, processing, review, storage, and analysis across LGAs and states across the country.
Scroll to Top

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.